NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DVA shares have increased by 9.2% and is now trading at $81.73.
View which stocks have been most impacted by COVID-19.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) released its earnings results on Thursday, July, 30th. The company reported $1.95 EPS for the quarter, beating analysts' consensus estimates of $1.30 by $0.65. The company earned $2.88 billion during the quarter, compared to analyst estimates of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%.
View Davita's earnings history.

Davita issued an update on its FY20 earnings guidance on Thursday, July, 30th. The company provided earnings per share guidance of $6.25-$6.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.11. The company issued revenue guidance of $11.5-$11.7 billion, compared to the consensus revenue estimate of $11.70 billion.

10 brokers have issued 12 month price objectives for Davita's shares. Their forecasts range from $57.00 to $100.00. On average, they expect Davita's share price to reach $71.17 in the next year. This suggests that the stock has a possible downside of 12.9%.
View analysts' price targets for Davita.

Media stories about DVA stock have been trending extremely negative on Thursday, InfoTrie reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Davita earned a news sentiment score of -4.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future.
View the latest news about Davita.

Davita saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 5,540,000 shares, a drop of 18.6% from the January 31st total of 6,810,000 shares. Based on an average daily volume of 1,260,000 shares, the days-to-cover ratio is currently 4.4 days. Approximately 4.5% of the company's shares are sold short.
View Davita's Short Interest.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), R1 RCM (RCM), MEDNAX (MD), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), AbbVie (ABBV), AT&T (T), AutoZone (AZO) and United Rentals (URI).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (2.22%), Robeco Institutional Asset Management B.V. (1.38%), LSV Asset Management (0.82%), Thornburg Investment Management Inc. (0.44%), Ensign Peak Advisors Inc (0.41%) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. (0.38%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz.
View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Prudential Financial Inc., Hexavest Inc., Thornburg Investment Management Inc., Mackay Shields LLC, and WINTON GROUP Ltd. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz.
View insider buying and selling activity for Davita.

DVA stock was acquired by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, LSV Asset Management, Todd Asset Management LLC, Robeco Institutional Asset Management B.V., Achmea Investment Management B.V., First Eagle Investment Management LLC, Victory Capital Management Inc., and Venturi Wealth Management LLC.
View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $81.73.

Davita has a market capitalization of $9.97 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]